Exodus Point Capital Management, LP Medpace Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$233.98 - $281.67 $2.33 Million - $2.8 Million	-9,940 Reduced 74.17%	3,462 $838,000
Q2 2023 Aug 10, 2023	SELL	$187.26 - $240.17 $734,995 - $942,667	-3,925 Reduced 22.65%	13,402 $3.22 Million
Q1 2023 May 11, 2023	BUY	$174.31 - $239.52 $1.14 Million - $1.56 Million	6,530 Added 60.48%	17,327 $3.26 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $264,793 - $391,966	-1,730 Reduced 13.81%	10,797 $2.29 Million
Q3 2022 Nov 10, 2022	BUY	$145.13 - $182.49 $1.82 Million - $2.29 Million	12,527 New	12,527 $1.97 Million
Q2 2022 Aug 19, 2022	SELL	$130.2 - $168.03 $174,598 - $225,328	-1,341 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $954,592 - $1.47 Million	-6,874 Reduced 83.68%	1,341 $219,000
Q4 2021 Feb 11, 2022	BUY	$182.74 - $227.9 $1.5 Million - $1.87 Million	8,215 New	8,215 $1.79 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $3.28 Million - $4.48 Million	-30,004 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $2.79 Million - $3.92 Million	30,004 New	30,004 $3.35 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.